Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 10 studies | 48% ± 19% | |
| epithelial cell | 8 studies | 59% ± 25% | |
| respiratory goblet cell | 6 studies | 69% ± 22% | |
| secretory cell | 6 studies | 48% ± 12% | |
| club cell | 5 studies | 58% ± 17% | |
| deuterosomal cell | 4 studies | 42% ± 6% | |
| squamous epithelial cell | 4 studies | 77% ± 14% | |
| luminal cell of prostate epithelium | 4 studies | 23% ± 8% | |
| duct epithelial cell | 3 studies | 35% ± 28% | |
| goblet cell | 3 studies | 50% ± 21% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 36% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 98% | 5899.98 | 239 / 245 | 75% | 293.34 | 378 / 502 |
| bladder | 90% | 22613.81 | 19 / 21 | 59% | 1284.41 | 297 / 504 |
| stomach | 94% | 79785.78 | 338 / 359 | 38% | 124.98 | 110 / 286 |
| skin | 91% | 299.41 | 1640 / 1809 | 17% | 11.11 | 78 / 472 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3290.58 | 1 / 1 |
| esophagus | 51% | 3765.41 | 731 / 1445 | 48% | 61.43 | 88 / 183 |
| pancreas | 10% | 51.17 | 34 / 328 | 76% | 362.46 | 135 / 178 |
| lung | 48% | 239.59 | 280 / 578 | 28% | 60.06 | 319 / 1155 |
| kidney | 71% | 176.19 | 63 / 89 | 4% | 19.55 | 33 / 901 |
| breast | 41% | 69.56 | 188 / 459 | 23% | 16.77 | 259 / 1118 |
| uterus | 8% | 95.33 | 14 / 170 | 50% | 169.40 | 230 / 459 |
| tonsil | 0% | 0 | 0 / 0 | 53% | 28.68 | 24 / 45 |
| intestine | 27% | 153.98 | 260 / 966 | 22% | 82.68 | 117 / 527 |
| ovary | 5% | 8.89 | 9 / 180 | 16% | 5.12 | 70 / 430 |
| adipose | 13% | 107.71 | 161 / 1204 | 0% | 0 | 0 / 0 |
| brain | 6% | 4.36 | 165 / 2642 | 0% | 0 | 0 / 705 |
| blood vessel | 6% | 12.62 | 79 / 1335 | 0% | 0 | 0 / 0 |
| adrenal gland | 5% | 3.84 | 12 / 258 | 1% | 0.10 | 2 / 230 |
| thymus | 4% | 8.23 | 28 / 653 | 1% | 0.23 | 4 / 605 |
| liver | 2% | 3.00 | 4 / 226 | 1% | 2.45 | 5 / 406 |
| spleen | 2% | 2.02 | 6 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 1% | 5.70 | 12 / 929 | 0% | 0 | 0 / 0 |
| muscle | 1% | 2.22 | 10 / 803 | 0% | 0 | 0 / 0 |
| heart | 1% | 1.25 | 9 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
| GO_0099601 | Biological process | regulation of neurotransmitter receptor activity |
| GO_0098552 | Cellular component | side of membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0033130 | Molecular function | acetylcholine receptor binding |
| Gene name | PSCA |
| Protein name | Prostate stem cell antigen |
| Synonyms | UNQ206/PRO232 |
| Description | FUNCTION: May be involved in the regulation of cell proliferation. Has a cell-proliferation inhibition activity in vitro. .; FUNCTION: May act as a modulator of nicotinic acetylcholine receptors (nAChRs) activity. In vitro inhibits nicotine-induced signaling probably implicating alpha-3:beta-2- or alpha-7-containing nAChRs. . |
| Accessions | H0YAA6 O43653 ENST00000513264.1 ENST00000301258.5 |
